A Phase I/II Study of HE3235 in Patients With Prostate Cancer

NCT00716794 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Harbor Therapeutics